127 related articles for article (PubMed ID: 1466952)
1. Phase I/II studies of the toxicity and immunogenicity of recombinant gp160 and p24 vaccines in HIV-infected individuals.
Zunich KM; Lane HC; Davey RT; Falloon J; Polis M; Kovacs JA; Masur H
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1335. PubMed ID: 1466952
[No Abstract] [Full Text] [Related]
2. Clinical trials of AIDS vaccines in seronegative volunteers: vectors and combinations.
Graham BS
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1327-8. PubMed ID: 1466951
[No Abstract] [Full Text] [Related]
3. Vaccine therapy using rgp 160 in early HIV infection.
Redfield R; Birx D; Ketter N; Polonis V; Johnson S; Davis C; Smith G; Oster C; Burke D
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1333. PubMed ID: 1361350
[No Abstract] [Full Text] [Related]
4. Immunization with recombinant gp160 prolongs the survival of HIV-1 transgenic mice.
Shirai A; Klinman DM
AIDS Res Hum Retroviruses; 1993 Oct; 9(10):979-83. PubMed ID: 8280480
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. Clin Exp Immun 1994;98:178-84.
DePalma L
Pediatr AIDS HIV Infect; 1995 Apr; 6(2):97-8. PubMed ID: 11361387
[No Abstract] [Full Text] [Related]
6. HIV experimental vaccines based on the iscom technology using envelope and GAG gene products.
Akerblom L; Nara P; Dunlop N; Putney S; Morein B
Biotechnol Ther; 1993; 4(3-4):145-61. PubMed ID: 8292967
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with gp160 in HIV.
Oyaizu N; Chirmule N; Pahwa S
N Engl J Med; 1992 Jan; 326(5):347; author reply 348. PubMed ID: 1728747
[No Abstract] [Full Text] [Related]
8. AIDS vaccine boosts immunity in HIV patients.
RN; 1991 Oct; 54(10):103. PubMed ID: 1925340
[No Abstract] [Full Text] [Related]
9. Current progress in HIV vaccines.
Westblom TU; Belshe RB; Gorse GJ
Mo Med; 1991 Nov; 88(11):762-5. PubMed ID: 1805131
[No Abstract] [Full Text] [Related]
10. Immunization of HIV-infected patients with rgp160: modulation of anti-rgp120 antibody spectrotype.
Biselli R; Loomis LD; Del Bono V; Burke DS; Redfield RR; Birx DL
J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1016-24. PubMed ID: 8083819
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of gp160 vaccinees in the hu-PBL-SCID mouse model.
Mosier DE; Gulizia RJ; MacIsaac P; Mathieson BJ; Smith G; Hu SL; Corey L; Greenberg P
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1387. PubMed ID: 1466962
[No Abstract] [Full Text] [Related]
12. Vaccination with gp160 in HIV.
Stanberry LR; Bernstein DI; Myers MG
N Engl J Med; 1992 Jan; 326(5):347-8. PubMed ID: 1728748
[No Abstract] [Full Text] [Related]
13. Enhancement of human immunodeficiency virus (HIV)-specific CD4+ and CD8+ cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccine.
Kundu SK; Katzenstein D; Moses LE; Merigan TC
Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11204-8. PubMed ID: 1360665
[TBL] [Abstract][Full Text] [Related]
14. USA: therapeutic AIDS vaccine trial debated.
Rowe PM
Lancet; 1992 Nov; 340(8829):1216. PubMed ID: 1359275
[No Abstract] [Full Text] [Related]
15. Trial results thwart HIV-vaccine hopes.
McCarthy M
Lancet; 1996 Apr; 347(9009):1173. PubMed ID: 8609757
[No Abstract] [Full Text] [Related]
16. HIV-1 recombinant poxvirus vaccine induces cross-protection against HIV-2 challenge in rhesus macaques.
Abimiku AG; Franchini G; Tartaglia J; Aldrich K; Myagkikh M; Markham PD; Chong P; Klein M; Kieny MP; Paoletti E
Nat Med; 1995 Apr; 1(4):321-9. PubMed ID: 7585061
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a vaccinia-derived recombinant HIV-1 gp160 candidate vaccine and its immunogenicity in chimpanzees.
Barrett N; Eder G; Dorner F
Biotechnol Ther; 1991; 2(1-2):91-106. PubMed ID: 1845126
[TBL] [Abstract][Full Text] [Related]
18. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.
Dis Markers; 1991; 9(1):51. PubMed ID: 1742945
[No Abstract] [Full Text] [Related]
19. Properties of an HIV 'vaccine'.
Wahren B; Sandström E; Wigzell H
Nature; 1993 Apr; 362(6420):505; author reply 505-6. PubMed ID: 8464491
[No Abstract] [Full Text] [Related]
20. The prospects for AIDS vaccines.
Koff WC
Hosp Pract (Off Ed); 1991 Apr; 26(4):99-106. PubMed ID: 2010483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
